Assignee
BioNTech SE
DE48 patents
Top patents by PatentIndex Score
US11547673B1Jan 10, 2023
Coronavirus vaccine
BioNTech SE12 citations90
US11395799B2Jul 26, 2022
Preparation and storage of liposomal RNA formulations suitable for therapy
BioNTech SE7 citations80
US11222711B2Jan 11, 2022
Predicting immunogenicity of T cell epitopes
BioNTech SE11 citations79
US11779659B2Oct 10, 2023
RNA constructs and uses thereof
BioNTech SE4 citations78
US12270813B2Apr 8, 2025
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
BioNTech SE2 citations75
US11878055B1Jan 23, 2024
Coronavirus vaccine
BioNTech SE2 citations71
US11267813B2Mar 8, 2022
Substituted imidazoquinolines
BioNTech SE3 citations71
US11559587B2Jan 24, 2023
RNA formulation for immunotherapy
BioNTech SE3 citations70
US12059498B2Aug 13, 2024
Preparation and storage of liposomal RNA formulations suitable for therapy
BioNTech SE3 citations69
US11925694B2Mar 12, 2024
Coronavirus vaccine
BioNTech SE1 citations69
US11046745B2Jun 29, 2021
Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof
BioNTech SE3 citations68
US11951185B2Apr 9, 2024
RNA constructs and uses thereof
BioNTech SE1 citations65
US12460198B2Nov 4, 2025
Method for reducing immunogenicity of RNA
BioNTech SE0 citations62
US12421319B2Sep 23, 2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease
BioNTech SE0 citations62
US12263215B2Apr 1, 2025
Cytotoxic immunostimulating particles and uses thereof
BioNTech SE0 citations62
US11873478B2Jan 16, 2024
Method for reducing immunogenicity of RNA
BioNTech SE0 citations62
US11814411B2Nov 14, 2023
Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137)
BioNTech SE0 citations62
US11760809B2Sep 19, 2023
Human monoclonal antibodies to ganglioside GD2
BioNTech SE0 citations62
US11298426B2Apr 12, 2022
Recombinant vaccines and use thereof
BioNTech SE0 citations62
US10927181B2Feb 23, 2021
Agonistic tumor necrosis factor (TNF) receptor binding agents
BioNTech SE0 citations62
US12385049B2Aug 12, 2025
Modification of RNA, producing an increased transcript stability and translation efficiency
BioNTech SE0 citations61
US12208136B2Jan 28, 2025
Coronavirus vaccine
BioNTech SE0 citations60
US12054485B2Aug 6, 2024
Substituted imidazoquinolines
BioNTech SE1 citations60
US11987569B2May 21, 2024
Substituted imidazoquinolines as agonists of TLR7
BioNTech SE1 citations60
US11660338B2May 30, 2023
Particles comprising a shell with RNA
BioNTech SE0 citations60
US11279684B2Mar 22, 2022
Substituted imidazoquinolines as agonists of TLR7
BioNTech SE1 citations60
US12378531B2Aug 5, 2025
Use of RNA for reprogramming somatic cells
BioNTech SE0 citations59
US12338448B2Jun 24, 2025
Trans-replicating RNA
BioNTech SE0 citations59
US12281322B2Apr 22, 2025
RNA replicon for versatile and efficient gene expression
BioNTech SE0 citations59
US12220484B2Feb 11, 2025
Stable formulations of lipids and liposomes
BioNTech SE0 citations59
US12133899B2Nov 5, 2024
Coronavirus vaccine
BioNTech SE0 citations59
US12054723B2Aug 6, 2024
Stabilization of poly(A) sequence encoding DNA sequences
BioNTech SE0 citations59
US11504419B2Nov 22, 2022
Individualized vaccines for cancer
BioNTech SE1 citations59
US12433911B2Oct 7, 2025
Preparation and storage of liposomal RNA formulations suitable for therapy
BioNTech SE0 citations58
US12410221B2Sep 9, 2025
Tumor antigens for determining cancer therapy
BioNTech SE0 citations58
US12186387B2Jan 7, 2025
Coronavirus vaccine
BioNTech SE0 citations58
US12516333B2Jan 6, 2026
3′-UTR sequences for stabilization of RNA
BioNTech SE0 citations57
US12168051B2Dec 17, 2024
Methods and compositions for stimulating immune response
BioNTech SE0 citations57
US11492628B2Nov 8, 2022
3′-UTR sequences for stabilization of RNA
BioNTech SE1 citations57
US12153041B2Nov 26, 2024
Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
BioNTech SE0 citations56
US12150947B2Nov 26, 2024
Formulation for administration of RNA
BioNTech SE0 citations56
US12516104B2Jan 6, 2026
Compositions and methods for diagnosis and treatment of cancer
BioNTech SE0 citations55
US11701413B2Jul 18, 2023
RNA for treatment of autoimmune diseases
BioNTech SE0 citations55
US11673939B2Jun 13, 2023
Compositions and methods for diagnosis and treatment of cancer
BioNTech SE1 citations55
US10729785B2Aug 4, 2020
Particles comprising protamine and RNA in combination with endosome destabilizing agents
BioNTech SE0 citations52
US11932693B2Mar 19, 2024
Monoclonal antibodies directed against programmed death-1 protein and their use in medicine
BioNTech SE0 citations43
US12305210B2May 20, 2025
In vitro transcription technologies
BioNTech SE0 citations35
US12346849B2Jul 1, 2025
System for supporting teamwork by means of augmented reality
BioNTech SE0 citations30